Accelerate your molecule from discovery to market
October 28-30, 2025
Messe FrankfurtMeet us at Booth: 9.1 Stand B48
Accelerating your molecule’s journey with end-to-end, integrated CDMO services
Early Phase development
Our integrated drug substance, drug product & toxicology services drive efficient and reliable early phase development progress and accelerate the journey to IND submission. Schedule a meeting to discuss how we can accelerate your molecule’s path to the clinic!
Scale up & Manufacturing
Our phase-appropriate scale-up and manufacturing solutions draw on 16 FDA-compliant sites to keep quality, compliance, and efficiency on track at every stage. Schedule a meeting to plan the right scale-up path for your phase.
Commercial Manufacturing
Ensure a smooth commercial launch and sustainable supply with Aurigene Pharmaceutical Services. Our reliable, compliant, large-scale supply solutions support your product’s success from launch through lifecycle. Schedule a meeting to discuss a reliable, compliant supply plan that supports your launch and long-term growth strategies.
Why Aurigene Pharmaceutical Services?
20+
Years of
Expertise
- 400+ projects from more than 100 global customers
- 15+ products in commercial phase
- 700+ dedicated scientists
8
USFDA inspected
GMP sites
- 4100+ KL capacity
- Reactor volume from 60L to 10KL
- Cryogenic reaction, High Potent and High-pressure reaction capabilities
- Unit operations like: SD, Hydrogenation, ATFD
- Dedicated production blocks for peptides, steroids, and PEG alcohol & PEG derivatives
2
R&D
Centres
- 10-acre dedicated R&D campus
- 210,000 sq. ft lab space
- 15+ dedicated labs for chemistry, biology and formulation along with analytical center of excellence
Meet our Experts
We are excited to meet you and explore potential opportunities for collaboration and partnership. To schedule a meeting with us, simply provide us with your information and we will be in touch to arrange a time that works for you. We are excited to connect with you and explore how we can work together to drive success in the industry.
Akhil Ravi
Chief Executive Officer
Dr. Srividya
Global Head, CDMO Services
Kapil Choudhury
Global Head - Business Development
PVR Bharadwaja
Head - Marketing and Strategy
Raj Sharma
Region Head - EU
Ashwini Kapoor
Director - Business Development Small Molecules CDMO, EU
Akshay Shukla
Sr. Director - Biologics
Nem Kaurin
Director - Business Development Small Molecules CDMO, NA
Services we Offer
Chemical Development Services
Aurigene Pharmaceutical Services provides a wide range of pharmaceutical drug development services for pre-clinical and clinical trials I, II and III wherein we synthesize New Chemical Entity (NCE) from few grams for efficacy and toxicology studies to multi-kilogram for clinical trial studies. These can be offered from GLP-compliant and cGMP environment to meet client requirements.
Formulation Development Services
Aurigene Pharmaceutical Services offers end-to-end formulation development services ranging from early development to clinical supplies for new chemical entities for the pharmaceutical, nutraceutical & animal healthcare industry along with life cycle extension of the products. We have the expertise along with the state-of-the-art infrastructure and diverse experience to develop formulations for your pre-clinical and clinical needs to support oral, topical & parenteral administration. Our formulation development effort revolves around developing the best formulation for your compound, focusing on the desired bioavailability and optimal stability of your drug product.Starting with comprehensive pre-formulation services Aurigene Pharmaceutical Services helps its clients to determine optimal dosage forms they can use for pre-clinical or clinical applications.
Manufacturing Services
Aurigene has access to the manufacturing facilities of Dr. Reddy’s and a network of strategic business partners. Our pharmaceutical drug manufacturing services offer a wide range of manufacturing services from a few kilos to multi tons of cGMP manufacturing of Key Starting Material (KSM) / Registered Starting Materials (RSM), advanced intermediates, APIs and finished formulations. We have manufacturing options across the globe, with our facilities located in India, the UK, Mexico and the US. With a strong legacy of supporting New Chemical Entity (NCE) manufacturing, drug substances and drug products commercial manufacturing, we are able to cater to Pharma, Specialty, Nutraceutical and Animal Health companies
The Aurigene expertise
Aurigene Pharmaceutical Services Limited is an integrated partner for global pharma companies. It covers the entire value chain for new therapeutics, from drug discovery, clinical research, and development to manufacturing APIs and formulation at commercial scales. It has development laboratories from discovery to clinical phase III for New Chemical and Biological Entities (NCEs/NBEs) and cGMP manufacturing facilities in the UK, Mexico, USA and India. The technology platforms include cytotoxic APIs, carbohydrates, steroids, PEG derivatives, prostaglandins, peptides and oligonucleotides. Large molecule discovery services include ADC, mAb, mRNA, CART-T as well as development services in mAb and protein therapeutics.
About CPHI Frankfurt
CPHI Frankfurt is the world’s leading pharmaceutical event, bringing together more than 62,000 professionals from over 166 countries. The event spans the entire pharma supply chain, including APIs, finished dosage forms, biopharmaceuticals, packaging, machinery, and cutting-edge technologies shaping the future of the industry.
With 2,400+ exhibitors and 200 expert speakers, CPHI Frankfurt creates a dynamic environment for networking, idea exchange, and business opportunities. It enables industry leaders, researchers, and executives to connect, collaborate, and explore partnerships on a global scale.
A hallmark of the event is its focus on innovation and knowledge-sharing. Attendees gain firsthand insights into advancements such as automation, AI, cleanroom technology, cold chain logistics, sustainable solutions, and next-generation bio-manufacturing. Dedicated conference tracks and themed zones offer deep dives into the most pressing challenges and opportunities in pharma.
CPHI Frankfurt 2025, taking place from 28–30 October at Messe Frankfurt, is the must-attend platform for professionals seeking to stay ahead of industry trends, build strategic connections, and discover new pathways for collaboration and growth.
CPHI Frankfurt
Meet us at Booth: 9.1 Stand B48
October 28-30, 2025Messe FrankfurtYou are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.
Leaving already?
Don't forget to join us at
CPHI Worldwide 2023.
October 24th-26th, 2023 | Barcelona, Spain
Get ready to accelerate your drug’s journey to the market